1-3 of 3
Roy Ervin Strowd III
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Pilot Study Evaluating Acalabrutinib for the Treatment of Relapsed/Refractory Primary and Secondary Central Nervous System Lymphomas

Christopher Dittus, Roy Ervin Strowd III, Kelly Hoye, Xianming Tan, Jordan Miller, Celeste Bello, Amir Khandani, Anne W. Beaven
Journal: Blood
Blood (2022) 140 (Supplement 1): 6616–6617.
https://doi.org/10.1182/blood-2022-165139
Published: 2022
Journal Articles

Safety Profile of Maintenance Obinutuzumab in Patients with Primary CNS Lymphoma in Complete Response

Nancy D. Doolittle, Prakash Ambady, David M. Peereboom, Douglas E. Ney, Larry Junck, Yoshie Umemura, Roy Ervin Strowd III, Glenn J. Lesser, David Schiff, Camilo E. Fadul, Michael Glantz, MD PhD, Erin M. Dunbar, Peter Barth, Edward Pan, Alissa A. Thomas, Rongwei Fu, Edward A. Neuwelt
Journal: Blood
Blood (2020) 136 (Supplement 1): 12.
https://doi.org/10.1182/blood-2020-134457
Published: 2020
Journal Articles

Anaplastic Myeloma Arising from Myeloma: Successful Management of Two Diseases in an Individual

Cesar Rodriguez, MD, Roy Ervin Strowd III, MD, David D Grier
Journal: Blood
Blood (2017) 130 (Supplement 1): 5410.
https://doi.org/10.1182/blood.V130.Suppl_1.5410.5410
Published: 2017